Your browser doesn't support javascript.
loading
Impact of exacerbations on lung function, resource utilization, and productivity: results from an observational, prospective study in adults with uncontrolled asthma.
Wisnivesky, Juan; Federmann, Emily; Eckert, Laurent; West, Erin; Amand, Caroline; Kamar, Driss; Teper, Ariel; Khan, Asif H.
Afiliação
  • Wisnivesky J; Division of General Internal Medicine, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
  • Federmann E; Division of Pulmonary and Critical Care Medicine, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
  • Eckert L; Division of General Internal Medicine, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
  • West E; Sanofi, Chilly-Mazarin, France.
  • Amand C; Epidemiology, Biostatistics and Prevention Institute, University of Zurich, Zurich, Switzerland.
  • Kamar D; Sanofi, Chilly-Mazarin, France.
  • Teper A; Ividata Life Science, Levallois-Perret, France.
  • Khan AH; Sanofi, Bridgewater Township, NJ, USA.
J Asthma ; 60(6): 1072-1079, 2023 06.
Article em En | MEDLINE | ID: mdl-36218309
ABSTRACT

Background:

Exacerbations have a major impact on the well-being of patients with uncontrolled asthma. This study evaluated lung function, healthcare resource utilization (HCRU), and productivity loss following asthma exacerbations.

Methods:

This single-center, observational, prospective cohort study recruited US patients presenting clinically with an acute asthma exacerbation; a reference group without exacerbations was included for comparison. Lung function (forced expiratory volume in 1 second [FEV1]) was collected at baseline, daily during Month 1, and monthly for Months 2-5, and reported as FEV1 percent predicted (FEV1pp). HCRU (outpatient visits to a healthcare practitioner, emergency room [ER] visits, and hospitalizations for asthma), oral corticosteroid (OCS) use, and asthma-related work/school absence were collected monthly for 6 months.

Results:

Overall, 150 patients were recruited (exacerbation n=102; reference n=48; mean [SD] age 42.7 [15.2] and 49.6 [12.4] years; female 73% and 71%). In both groups, similar trends were observed in FEV1, with significant improvement from baseline to Week 1 (p<0.05), followed by a continuous decline. FEV1p was 7.7% lower at baseline and 8.6% lower at Month 5 in the exacerbation group versus the reference group. The exacerbation group had significantly higher rates of OCS prescription during follow-up versus reference group (p=0.04). Over half (52.9%) of patients in the exacerbation group had a recurrent exacerbation during follow-up, increased HCRU (outpatient visits, ER visits, and hospitalizations), and impaired productivity.

Conclusion:

Although patients with exacerbations had rapid recovery of lung function, this was not maintained and declined faster than in patients without exacerbations. Additionally, patients experienced increased HCRU after exacerbations.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Asma Tipo de estudo: Observational_studies / Risk_factors_studies Limite: Adult / Female / Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Asma Tipo de estudo: Observational_studies / Risk_factors_studies Limite: Adult / Female / Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article